CPT code 23071 represents surgical excision of a soft-tissue mass or tumor located immediately under the skin of the shoulder, with the specimen size documented as 3 cm or greater. This code is used to report definitive removal of subcutaneous shoulder masses and the submission of the specimen for pathologic analysis. Nationally, accurate use of this code matters for clinical documentation, surgical coding consistency, and appropriate payment for procedures that require more extensive dissection and specimen handling.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and common billing considerations relevant to hospital outpatient departments and ambulatory surgery centers. The publication outlines benchmarks and coding guidance to assist coding professionals and revenue cycle staff in recognizing when the 3 cm size threshold applies and how that affects procedural reporting. It also highlights policy updates and payer coverage considerations that commonly influence claim adjudication for soft-tissue excisions in the shoulder.

This national overview is intended for coding professionals, surgical teams, and billing analysts seeking a clear summary of the clinical intent and billing implications of CPT code 23071. Data not available in the input is noted where applicable.